project id: TCGA-SKCM; case submitter id: TCGA-BF-A1Q0; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.3; age at index: 80; days to birth: -29380; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1930; age at diagnosis: 29380; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 831.0; icd 10 code: C44.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 75; initial weight: 110.0; sample id: b68cfb6b-4249-4855-8278-b18c0f561efd; sample submitter id: TCGA-BF-A1Q0-01A; portion id: 1effd919-273b-4d8a-8b45-2c3545d6fc6e; portion submitter id: TCGA-BF-A1Q0-01A-21; slide id: 136952e7-8b68-453e-bf14-63c71689679e; slide submitter id: TCGA-BF-A1Q0-01A-02-TSB; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 55.0; percent tumor cells: 45.0; percent tumor nuclei: 70.0; section location: TOP;